Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease

被引：28

作者：

Alber, HF ^{[1
]}

Frick, M ^{[1
]}

Dulak, J ^{[1
]}

Dörler, J ^{[1
]}

Zwick, RH ^{[1
]}

Dichtl, W ^{[1
]}

Pachinger, O ^{[1
]}

Weidinger, F ^{[1
]}

机构：

[1] Univ Innsbruck, Dept Cardiol, A-6020 Innsbruck, Austria

来源：

HEART | 2005年 / 91卷 / 03期

关键词：

D O I：

10.1136/hrt.2003.021311

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：365 / 366

页数：2

共 5 条

[1]

Alber HF, 2002, J AM COLL CARDIOL, V39, P1951

[2] Vascular endothelial growth factor and its receptor, Flt-l, in the plasma of patients with coronary or peripheral atherosclerosis, or type II diabetes [J].

Blann, AD ;

Belgore, FM ;

McCollum, CN ;

Silverman, S ;

Lip, PL ;

Lip, GYH .

CLINICAL SCIENCE, 2002, 102 (02) :187-194

[3] Vascular endothelial growth factor enhances atherosclerotic plaque progression [J].

Celletti, FL ;

Waugh, JM ;

Amabile, PG ;

Brendolan, A ;

Hilfiker, PR ;

Dake, MD .

NATURE MEDICINE, 2001, 7 (04) :425-429

[4] Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1-to 3-vessel coronary artery disease [J].

Fleisch, M ;

Billinger, M ;

Eberli, FR ;

Garachemani, AR ;

Meier, B ;

Seiler, C .

CIRCULATION, 1999, 100 (19) :1945-1950

[5] Gene therapy for myocardial angiogenesis -: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia [J].

Losordo, DW ;

Vale, PR ;

Symes, JF ;

Dunnington, CH ;

Esakof, DD ;

Maysky, M ;

Ashare, AB ;

Lathi, K ;

Isner, JM .

CIRCULATION, 1998, 98 (25) :2800-2804

← 1 →